Rani Therapeutics (RANI)
(Delayed Data from NSDQ)
$6.68 USD
+0.12 (1.83%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $6.69 +0.01 (0.15%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMDetailed Estimates
EPS Estimates
Exp Earnings Date | 5/8/24 |
---|---|
Current Quarter | -0.23 |
EPS Last Quarter | -0.27 |
Last EPS Surprise | 12.90% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.94 |
Next Year | -0.81 |
EPS (TTM) | -1.33 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.23 | -0.26 | -0.94 | -0.81 |
# of Estimates | 1 | 1 | 4 | 3 |
Most Recent Consensus | NA | NA | -0.83 | -0.93 |
High Estimate | -0.23 | -0.26 | -0.83 | -0.68 |
Low Estimate | -0.23 | -0.26 | -1.01 | -0.93 |
Year ago EPS | -0.33 | -0.37 | -1.33 | -0.94 |
Year over Year Growth Est. | 30.30% | 29.73% | 29.32% | 13.83% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 1 | 3 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.23 | -0.26 | -0.94 | -0.81 |
7 Days Ago | -0.23 | -0.26 | -0.94 | -0.81 |
30 Days Ago | -0.23 | -0.26 | -0.94 | -0.81 |
60 Days Ago | -0.24 | -0.27 | -1.16 | -0.82 |
90 Days Ago | -0.24 | -0.27 | -1.19 | -0.82 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.23 | -0.26 | -0.83 | -0.81 |
Zacks Consensus Estimate | -0.23 | -0.26 | -0.94 | -0.81 |
Earnings ESP | 0.00% | 0.00% | 11.70% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.27 | -0.36 | -0.37 | -0.33 | NA |
Estimate | -0.31 | -0.47 | -0.40 | -0.47 | NA |
Difference | 0.04 | 0.11 | 0.03 | 0.14 | 0.08 |
Surprise | 12.90% | 23.40% | 7.50% | 29.79% | 18.40% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more